Related Experiment Video
Updated: Feb 6, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite
Tommaso C Bulfone1,2,3, Stephen P Samuel1,4, Philip E Bickler3
1California Academy of Sciences, San Francisco, 94118 CA, USA.
Abstract:
The World Health Organization (WHO) recently added snakebite envenoming to the priority list of Neglected Tropical Diseases (NTD). It is thought that ~75% of mortality following snakebite occurs outside the hospital setting, making the temporal gap between a bite and antivenom administration a major therapeutic challenge. Small molecule therapeutics (SMTs) have been proposed as potential prereferral treatments for snakebite to help address this gap. Herein, we discuss the characteristics, potential uses, and development of SMTs as potential treatments for snakebite envenomation. We focus on SMTs that are secretory phospholipase A2 (sPLA2) inhibitors with brief exploration of other potential drug targets on venom molecules.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Initiation of Translation
Heart Failure VI: Adjunct Therapies
Transcription Initiation
The promoters and enhancers and their accessory proteins allow tight regulation of...
Molecules and Compounds
Therapeutic Index

